Home/Filings/4/0000899243-20-015822
4//SEC Filing

David Nathaniel E 4

Accession 0000899243-20-015822

CIK 0001463361other

Filed

Jun 8, 8:00 PM ET

Accepted

Jun 9, 4:44 PM ET

Size

5.3 KB

Accession

0000899243-20-015822

Insider Transaction Report

Form 4
Period: 2020-06-05
David Nathaniel E
DirectorPresident
Transactions
  • Purchase

    Common Stock, $0.0001 par value

    2020-06-05$8.90/sh+3,200$28,4782,327,186 total
Footnotes (2)
  • [F1]Represents the weighted average purchase price for the entire number of shares purchased. The actual purchase prices vary between $8.8994 and $8.8995 per share. Information on the exact number of shares purchased at each purchase price can be obtained from Issuer upon request.
  • [F2]Includes Restricted Stock Units which vest over time measured from the grant date.

Issuer

Unity Biotechnology, Inc.

CIK 0001463361

Entity typeother

Related Parties

1
  • filerCIK 0001559531

Filing Metadata

Form type
4
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 4:44 PM ET
Size
5.3 KB